A diabetic client who is currently taking metformin is ordered a computerized tomography (CT) scan with contrast. The nurse understands that the client's metformin should be discontinued how many hours before receiving intravenous (IV) contrast?
24 hours
12 hours
6 hours
48 hours
The Correct Answer is B
A. Discontinuing metformin 24 hours before a CT scan is longer than necessary and not standard practice.
B. It is generally recommended that metformin be held for at least 12 hours before the administration of IV contrast to reduce the risk of lactic acidosis, especially in clients with renal impairment.
C. Six hours is insufficient time to ensure the medication is cleared from the system, considering the potential risks.
D. Discontinuing metformin for 48 hours is overly cautious and not necessary unless there are complications that arise after the contrast is administered.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is C
Explanation
A. Allopurinol is a xanthine oxidase inhibitor used for chronic gout management and prevention, not for acute attacks.
B. Febuxostat is also used for chronic management of gout and not effective for immediate relief of an acute attack.
C. Colchicine is indicated for the treatment of acute gout flares as it helps reduce inflammation and pain associated with gout attacks.
D. Physostigmine is an antidote for anticholinergic toxicity and has no role in treating gout.
Correct Answer is B
Explanation
A. Methylprednisolone does not contain soy products and is not contraindicated for clients with a soybean allergy.
B. Ipratropium bromide is often formulated with soy lecithin as a stabilizer, making it contraindicated for individuals allergic to soybeans.
C. Montelukast is a leukotriene receptor antagonist and does not contain soy products, so it is safe for this client.
D. Albuterol does not contain soy products and is generally safe for clients with a soybean allergy.